Search

While the number of clinical experiments investigating the effects of non-steroid antiinflammatory drugs (NSAIDs) on the cardiovascular (CV) events has significantly increased over the last two decades, basic research related to the mechanism by which NSAIDs cause CV dysfunction is limited. High variability in the clinical trials conducted (different populations, dosages, exposure and types of NSAIDs) has led to results which are difficult to interpret and compare between studies. Are there some NSAIDs safer than other from the standpoint of CV risk? We have try to answer at some aspects of this question. [ABSTRACT FROM AUTHOR]